Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacksCarolin Schwake, Theodoros Ladopoulos, Vivien Häußler, et al.Eclinicalmedicine|February 22, 2024
Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access programMaximilian Wiesenfarth, Johannes Dorst, David Brenner, et al.Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.Neurology|October 1, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European CohortMarius Ringelstein, Susanna Asseyer, Gero Lindenblatt, et al.Annals of Neurology|December 12, 2023
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGADAnkelien Duchow, Judith Bellmann-Strobl, Tim Friede, et al.Therapeutic Advances in Neurological Disorders|November 24, 2025
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort studyStefan Buchka, Alexander Hapfelmeier, Jan S Kirschke, et al.Ebiomedicine|August 1, 2025
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisBrian C Zhang, Tilman Schneider-Hohendorf, Rebecca Elyanow, et al.Frontiers in Immunology|April 28, 2025
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)Julian Reza Kretschmer, Daria Tkachenko, Tania Kümpfel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysisAhmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.Pageof 7